4.7 Article

Does Obstetric Brachial Plexus Injury Influence Speech Dominance?

Journal

ANNALS OF NEUROLOGY
Volume 65, Issue 1, Pages 57-66

Publisher

WILEY
DOI: 10.1002/ana.21538

Keywords

-

Funding

  1. Bolyai Fellowship
  2. Habilitas Scholarship MFB
  3. Hungarian Neuroimaging Foundation
  4. Hungarian Medical Research Council [ETT 219/2006, ETT 176/2006]
  5. Hungarian Research Fund [OTKA-NKTH F68720]

Ask authors/readers for more resources

Objective: Right-handedness and left-sided language lateralization is an unresolved mystery With unknown cause/effect relations. Most studies suggest that the language lateralization is related to a fundamental brain asymmetry: right-handedness may be secondary. We analyzed the possibility of an opposite cause/effect relation: whether asymmetric hand usage (as a cause) call influence language lateralization (as a consequence). Methods: We determined language lateralization by functional magnetic resonance imaging in 15 subjects whose upper limb (UL) had been injured at birth because of unilateral damage of the brachial plexus. These subjects were able to use only one (the noninjured) UL perfectly. Results: We found correlation between the severity of right-sided UL injuries and hand usage dysfunction and the degree of left-to-right shift of language lateralization. There was, however, not a complete switch of language lateralization. Interpretation: Right-sided UL injury can induce a left-to-right shift in language lateralization, suggesting that hand usage can influence language lateralization. These findings may contradict the broadly accepted theory that right-handedness is a secondary phenomenon caused by left-sided hemispheric language lateralization. However, the cause/effect problem between asymmetric hand usage and language lateralization is not resolved in this study. Our Findings may support the theory that gestures had a crucial role in human language evolution and is a part of the language system even today.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

THN 102 for Excessive Daytime Sleepiness Associated with Parkinson's Disease: A Phase 2a Trial

Jean-Christophe Corvol, Jean-Philippe Azulay, Bjorn Bosse, Yves Dauvilliers, Luc Defebvre, Fabian Klostermann, Norbert Kovacs, David Maltete, William G. Ondo, Rajesh Pahwa, Werner Rein, Stephane Thobois, Martin Valis, Aleksandar Videnovic, Olivier Rascol

Summary: The study of THN102 in PD patients with EDS showed that the 200/2 dose demonstrated efficacy and good tolerability, supporting further development. On the other hand, the 200/18 dose did not show significant improvement.

MOVEMENT DISORDERS (2022)

Article Clinical Neurology

Epilepsy is overrepresented among young people who died from COVID-19: Analysis of nationwide mortality data in Hungary

Reka A. Horvath, Zsofia Suto, Balazs Cseke, Daniel Schranz, Gergely Darnai, Norbert Kovacs, Imre Janszky, Jozsef Janszky

Summary: This study aimed to assess the prevalence of epilepsy among COVID-related deaths and found that epilepsy was more common among COVID-19 patients who died under the age of 50.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2022)

Article Neurosciences

Outcomes Impacting Quality of Life in Advanced Parkinson's Disease Patients Treated with Levodopa-Carbidopa Intestinal Gel

Norbert Kovacs, Lars Bergmann, Marieta Anca-Herschkovitsch, Esther Cubo, Thomas L. Davis, Robert Iansek, Mustafa S. Siddiqui, Mihaela Simu, David G. Standaert, K. Ray Chaudhuri, Paul Bourgeois, Tianming Gao, Pavnit Kukreja, Francesco E. Pontieri, Jason Aldred

Summary: Motor and non-motor symptoms of Parkinson's disease have an impact on health-related quality of life (HRQoL), and improvements in HRQoL are correlated with improvements in non-motor symptoms and sleep. LCIG treatment can improve HRQoL.

JOURNAL OF PARKINSONS DISEASE (2022)

Article Clinical Neurology

European Academy of Neurology guidance for developing and reporting clinical practice guidelines on rare neurological diseases

Katina Aleksovska, Teia Kobulashvili, Joao Costa, Georg Zimmermann, Karen Ritchie, Carola Reinhard, Luca Vignatelli, Alessandra Fanciulli, Maxwel Damian, Lucia Pavlakova, Jean-Marc Burgunder, Svetlana Kopishinskaya, Martin Rakusa, Norbert Kovacs, Fusun Ferda Erdogan, Lori Renna Linton, Massimiliano Copetti, Costanza Lamperti, Serenella Servidei, Theresina Evangelista, Segolene Ayme, Davide Pareyson, Johann Sellner, Christian Krarup, Marianne de Visser, Peter van den Bergh, Antonio Toscano, Holm Graessner, Thomas Berger, Claudio Bassetti, Marie Vidailhet, Eugene Trinka, Guenther Deuschl, Antonio Federico, Maurizio A. Leone

Summary: This article introduces the impact of rare diseases on patients and the existing problems within the European Union. It also provides recommendations and methods for developing and reporting high-quality clinical practice guidelines (CPGs) for rare neurological diseases (RNDs). Through a consensus procedure, 63 final items were identified. These recommendations provide solutions to the specific issues of RNDs and are considered as a starting point for further harmonization and improving the quality of CPGs.

EUROPEAN JOURNAL OF NEUROLOGY (2022)

Article Geriatrics & Gerontology

Examination of pituitary adenylate cyclase-activating polypeptide in Parkinson's disease focusing on correlations with motor symptoms

Daniel Pham, Beata Polgar, Tunde Toth, Adel Jungling, Norbert Kovacs, Istvan Balas, Endre Pal, Dora Szabo, Balazs Daniel Fulop, Dora Reglodi, Zalan Szanto, Robert Herczeg, Attila Gyenesei, Andrea Tamas

Summary: The study found that PACAP levels were significantly decreased in PD patients without DBS therapy and in the akinetic-rigid subtype. However, there were no significant correlations between PACAP levels and other clinical parameters. The results suggest that monitoring PACAP alterations in PD patients could improve therapeutic interventions and provide a clearer prognosis for the disease.

GEROSCIENCE (2022)

Article Clinical Neurology

Motor and nonmotor symptoms in patients treated with 24-hour daily levodopa-carbidopa intestinal gel infusion: Analysis of the COmedication Study assessing Mono- and cOmbination therapy with levodopa-carbidopa inteStinal gel (COSMOS)

Norbert Kovacs, Jozsef Szasz, Lydia Vela-Desojo, Per Svenningsson, Samira Femia, Juan Carlos Parra, Olga Sanchez-Solino, Lars Bergmann, Tanya Gurevich, Alfonso Fasano

Summary: This study compared motor and nonmotor outcomes in APD patients receiving 24-hour versus 16-hour LCIG treatment. The results showed reductions in off time, dyskinesia, and prevalence of most symptoms in both treatment groups. Significant differences were found in freezing of gait, urinary symptoms, and cognitive impairment between the two groups.

PARKINSONISM & RELATED DISORDERS (2022)

Article Multidisciplinary Sciences

Increased prevalence of minor physical anomalies in patients with epilepsy

Dalma Tenyi, Tamas Tenyi, Gyorgyi Csabi, Sara Jeges, Beata Bone, Katalin Lorincz, Norbert Kovacs, Jozsef Janszky

Summary: This study aimed to investigate the occurrence and distribution of minor physical anomalies (MPAs) in adult epilepsy patients. The results showed that MPAs were more common in epilepsy patients and were positively associated with antiepileptic drug therapy resistance. This finding contributes to the understanding of the neurodevelopmental etiology of epilepsy and provides a basis for early non-pharmacological treatment.

SCIENTIFIC REPORTS (2022)

Article Clinical Neurology

Dystonia management across Europe within ERN-RND: current state and future challenges

Liesanne M. Centen, David Pinter, Martje E. van Egmond, Holm Graessner, Norbert Kovacs, Anne Koy, Belen Perez-Duenas, Carola Reinhard, Marina A. J. Tijssen, Sylvia Boesch

Summary: This study evaluated the current state of dystonia management in Europe and found that accessibility was only considered "satisfactory" in nearly half of the surveyed countries, with over half of the countries facing challenging access to genetic and neurophysiological testing. Main oral medications and botulinum toxin were available in all countries, but deep brain stimulation (DBS) was easily accessible in only one-third of the countries. For pediatric dystonia, over half of the countries had experts and specific training available.

JOURNAL OF NEUROLOGY (2023)

Article Multidisciplinary Sciences

Potential clinical and economic benefits of remote deep brain stimulation programming

David Pinter, Evelyn Jardahazi, Jozsef Janszky, Norbert Kovacs

Summary: Teleprogramming for deep brain stimulation (DBS) can reduce travel and financial burdens for patients, especially during special situations like the COVID-19 pandemic. Research shows a significant decrease in the number of in-person visits during the pandemic.

SCIENTIFIC REPORTS (2022)

Article Psychiatry

Sudden gamer death: non-violent death cases linked to playing video games

Diana Kuperczko, Peter Kenyeres, Gergely Darnai, Norbert Kovacs, Jozsef Janszky

Summary: This study investigated 24 cases of deaths related to playing video games, most of which involved young males aged between 11 and 40. The majority of cases occurred in Southeast Asia, with 12 deaths happening in internet cafes. Prolonged gaming sessions, dehydration, and other factors like sleep deprivation and stress contributed to the deaths.

BMC PSYCHIATRY (2022)

Article Clinical Neurology

Are Parkinson's disease patients referred too late for device-aided therapies and how can better informed and earlier referrals be encouraged?

Fran Borovecki, Romana Perkovic, Norbert Kovacs, Peter A. A. LeWitt, Monika Rudzinska Bar, Regina Katzenschlager

Summary: In advanced Parkinson's disease, motor and non-motor symptoms worsen and become harder to treat. When oral therapy is insufficient in controlling motor complications, device-aided treatments, such as infusion therapies and deep brain stimulation, should be considered. These treatments should be provided according to guidelines and treatment standards, and ensuring availability and education for patients and physicians is crucial.

JOURNAL OF NEURAL TRANSMISSION (2023)

Meeting Abstract Clinical Neurology

Prospective, Multicenter, International Registry of Deep Brain Stimulation for Essential Tremor

G. Deuschl, R. Schuurman, G. Loret, N. Kovacs, M. Blazquez Estrada, F. Clement, J. Il Lee, L. Chen, R. Jain

MOVEMENT DISORDERS (2022)

Meeting Abstract Clinical Neurology

Reported Clinical and Quality-of-Life Outcomes With 24-Hour Levodopa-Carbidopa Intestinal Gel Administration Compared With 16-Hour Administration

N. Kovacs, M. Simu, O. Sanchez Solino, J. Parra, J. Alcazar, S. Snedecor, V. Fung

MOVEMENT DISORDERS (2022)

Meeting Abstract Clinical Neurology

Levodopa-Carbidopa Intestinal Gel Improves Long-term Parkinson's Disease Symptoms: Final Analysis of the DUOGLOBE Study

K. Chaudhuri, N. Kovacs, F. Pontieri, J. Aldred, P. Bourgeois, T. Davis, E. Cubo, M. Anca-Herschkovitsch, R. Iansek, M. Siddiqui, M. Simu, L. Bergmann, P. Kukreja, O. Ladhani, J. Jia, D. Standaert

EUROPEAN JOURNAL OF NEUROLOGY (2022)

Meeting Abstract Clinical Neurology

Dyskinesia Signs and Symptoms, and Quality of Life in Parkinson's Disease: Post Hoc Analysis From the DYSCOVER Study

E. Freire Alvarez, P. Vanni, E. Kurca, L. Lopez Manzanares, N. Kovacs, C. Spanaki, T. Gao, L. Bergmann, O. Sanchez-Solino, L. Barbato

EUROPEAN JOURNAL OF NEUROLOGY (2022)

No Data Available